IUHSA
DNLI icon

Itau Unibanco Holding S.A.’s Denali Therapeutics DNLI Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-268
Closed -$6.17K – 537
2023
Q1 		$6.17K Hold
268
– – ﹤0.01% 472
2022
Q4 		$7.45K Sell
268
-1,130
-81% -$33.6K ﹤0.01% 474
2022
Q3 		$43K Sell
1,398
-553
-28% -$18K ﹤0.01% 399
2022
Q2 		$57K Buy
1,951
+3
+0.2% +$79 ﹤0.01% 325
2022
Q1 		$63K Hold
1,948
– – ﹤0.01% 298
2021
Q4 		$88K Buy
1,948
+1,569
+414% +$74.3K ﹤0.01% 227
2021
Q3 		$19K Buy
379
+10
+3% +$564 ﹤0.01% 340
2021
Q2 		$29K Buy
+369
New +$22.8K ﹤0.01% 265

Other funds holding DNLI

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Itau Unibanco Holding S.A.'s DNLI Position: Q2 2023 in Review

Itau Unibanco Holding S.A. sold out of Denali Therapeutics (DNLI) in Q2 2023, closing a stake of 268 shares — an estimated $6.17K sold.

Itau Unibanco Holding S.A. first reported a position in DNLI in Q2 2021 and held it in 8 quarters. The position peaked at $88K in Q4 2021. 203 funds tracked by Wall St. Rank hold DNLI as of Q2 2023.

  • Itau Unibanco Holding S.A. reported no remaining Denali Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 268 Denali Therapeutics shares in Q2 2023, an estimated $6.17K.
  • Itau Unibanco Holding S.A. first reported a position in Denali Therapeutics in Q2 2021 and held it in 8 quarters.
  • Itau Unibanco Holding S.A.'s Denali Therapeutics position peaked at $88K in Q4 2021.
  • 203 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2023.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2023, filed 14 Aug 2023.